Rivals Sun Pharma and Cipla beat third-quarter profit estimates, while Dr Reddy's missed expectations. All three drugmakers ...

The EBITDA margin stood at 26% in the reporting quarter versus 23.1% YoY. The results came after the close of the market ...

Generic injectables maker Gland Pharma on February 3 reported a 7% rise in third-quarter profit, as lower expenses helped ...

For Nifty-50 index, 23,270 and 23,100 would act as key support zones, while the 50-day SMA, 23,810 and 23,900 could be the ...

Hindustan Media Ventures Ltd (HMVL) on Monday reported a consolidated profit after tax of Rs 18 crore in the December quarter ...

Subin Baral, EY global life sciences deals leader, told GEN M&A deals are expected to increase in 2025, driven by biopharmas that are eager to recoup revenues they expect to lose as their aging ...

The company clocked a 4% increase in net profit, which stood at ₹4.53 crore for Q2 of the ongoing financial year. This ...

Indian generic injectables maker Gland Pharma reported a 7% rise in third-quarter profit on Monday, as lower expenses helped mitigate the impact from production issues at its French unit Cenexi.

Despite broader challenges, ASML's backlog remains healthy, and management expects a recovery in H2 2025. Read why ASML stock ...

The Indian stock market closed on the upside, with the Auto and IT and Consumption sectors pulled the market up. The Nifty 50 ...

The number of UK homes with a streaming service subscription dipped slightly in the last quarter of 2024. 20 million UK homes ...

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look ...